...
【24h】

Acute Kidney Injury Occurring in a Patient Initiated on Dulaglutide

机译:在杜拉格尔蛋白质发起的患者中发生急性肾脏损伤

获取原文
获取原文并翻译 | 示例
           

摘要

Reports of acute kidney injury (AKI) have been reported with 2 glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide and liraglutide. No case reports of AKI or renal impairment associated with dulaglutide have been published. The patient is a 63-year-old female smoker with type 2 diabetes mellitus, hypertension, hyperlipidemia, heart failure with reduced ejection fraction, category G3b chronic kidney disease, and hypothyroidism treated with metformin 850 mg 3 times daily, canagliflozin 300 mg daily, glipizide 10 mg twice daily, lisinopril 10 mg daily, simvastatin 40 mg daily, furosemide 40 mg daily, aspirin 81 mg daily, carvedilol 12.5 mg twice daily, and levothyroxine 88 mcg daily.
机译:据报道,急性肾脏损伤(AKI)的报道已用2种胰高血糖素肽-1受体激动剂(GLP-1RA),exenatide和Liraglutide。 没有出版任何与杜拉格拉特相关的AKI或肾脏损害报告已发表。 患者是一名63岁的女性吸烟者,2型糖尿病,高血压,高脂血症,心力衰竭,射血分数降低,G3B类慢性肾脏病,和甲状腺素治疗的甲状腺功能亢进,每日3次3次3次,每天300毫克,每日300毫克,每日300毫克,每日300毫克,每日300毫克,每日300毫克,每天300毫克,每日300毫克,每天300毫克,每日300毫克, Glipizide每天10毫克两次,Lisinopril每日10毫克,辛伐他汀每日40毫克,呋塞米每日40毫克,Aspirin 81毫克每日81毫克,Carvedilol每日两次,每天两次,每天左旋甲肾上腺素88毫克。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号